Variant report
Variant | esv3451365 |
---|---|
Chromosome Location | chr2:186410207-186412305 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-FSIP2-5 | chr2:186411283-186411299 | NONHSAT075962 |
2 | lnc-FSIP2-5 | chr2:186410628-186411001 | NONHSAT075962 |
3 | lnc-FSIP2-5 | chr2:186411316-186411619 | NONHSAT075962 |
4 | lnc-FSIP2-5 | chr2:186410448-186410599 | NONHSAT075962 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs563658591 | chr2:186410210-186410211 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs113217356 | chr2:186410230-186410231 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs531063313 | chr2:186410237-186410238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs552744935 | chr2:186410247-186410248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs10931182 | chr2:186410296-186410297 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs535216471 | chr2:186410318-186410319 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs557899605 | chr2:186410343-186410344 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs547203094 | chr2:186410383-186410384 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs576191566 | chr2:186410426-186410427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs71405631 | chr2:186410437-186410438 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs75883150 | chr2:186410447-186410448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs565764660 | chr2:186410477-186410478 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs536276474 | chr2:186410481-186410482 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs55908230 | chr2:186410549-186410550 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs577174436 | chr2:186410566-186410567 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs373974998 | chr2:186410620-186410621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs183676975 | chr2:186410656-186410657 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs142438255 | chr2:186410659-186410660 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs113806168 | chr2:186410683-186410684 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs188682711 | chr2:186410736-186410737 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs376804368 | chr2:186410757-186410758 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs115765939 | chr2:186410768-186410769 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs561882231 | chr2:186410826-186410827 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs6731561 | chr2:186410869-186410870 | Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs559438959 | chr2:186410884-186410885 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs574562662 | chr2:186410893-186410894 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs541822548 | chr2:186410896-186410897 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs563299305 | chr2:186410919-186410920 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs150910138 | chr2:186410946-186410947 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs577266931 | chr2:186411012-186411013 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs376548340 | chr2:186411013-186411014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs564779570 | chr2:186411014-186411015 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs528712629 | chr2:186411035-186411036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs540792780 | chr2:186411036-186411037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs547181090 | chr2:186411037-186411038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs114666064 | chr2:186411045-186411046 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs6718332 | chr2:186411049-186411050 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
38 | rs527600662 | chr2:186411056-186411057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs548297700 | chr2:186411063-186411064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs569597512 | chr2:186411065-186411066 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs549361358 | chr2:186411071-186411072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs113028372 | chr2:186411075-186411076 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs201157290 | chr2:186411081-186411082 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs71407823 | chr2:186411089-186411090 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs200556688 | chr2:186411095-186411096 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs537031295 | chr2:186411099-186411100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs558615668 | chr2:186411102-186411103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs147729776 | chr2:186411113-186411114 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs534540338 | chr2:186411114-186411115 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs557305267 | chr2:186411119-186411120 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 18522746 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Facial dysmorphism | 20548289 | CNVD |
Mental retardation | 20548289 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Autism | 19329560 | CNVD |
Autism | 22543975 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:186381400-186432400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |